首页> 美国卫生研究院文献>Obesity Science Practice >Lifestyle modification program LIFE is LIGHT in patients with type 2 diabetes mellitus and obesity: Results from a 48‐week multicenter non‐randomized parallel‐group open‐label study

【2h】

Lifestyle modification program LIFE is LIGHT in patients with type 2 diabetes mellitus and obesity: Results from a 48‐week multicenter non‐randomized parallel‐group open‐label study

机译：生活方式修改计划寿命是光线患者2型糖尿病和肥胖症：48周多中心非随机并行组开放标签研究的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Obesity is a potential risk factor for development of type 2 diabetes mellitus (T2DM). To achieve long‐term weight reduction in patients with T2DM and obesity using comprehensive lifestyle management program (LMP).

机译：肥胖是2型糖尿病（T2DM）的发育的潜在危险因素。使用全面的生活方式管理计划（LMP）实现T2DM和肥胖患者的长期减重。

著录项

期刊名称 Obesity Science Practice
作者
Gagik R. Galstyan; Farida V. Valeeva; Svetlana I. Motkova; Elena V. Surkova; Larisa V. Savelyeva; Larisa M. Rudina; Krishnan Ramanathan; Ekaterina Sokareva; Kristina Bondareva; Marina V. Shestakova;
展开▼
作者单位

展开▼
年(卷),期 2021(7),4
年度 2021
页码 368–378
总页数 11
原文格式 PDF
正文语种
中图分类营养学;
关键词

机译：生活方式修改;肥胖;超重;2型糖尿病;

相似文献

外文文献
中文文献
专利

1. Liraglutide Versus Sitagliptin in a 24-week, Multicenter, Open-label, Randomized, Parallel-group Study in Japanese Type 2 Diabetes Mellitus Patients Responding Inadequately to a Sulfonylurea and/or One or Two Other Oral Antidiabetic Drugs (JDDM 33) [J] . Hiroki Yokoyama, Koichi Hirao, Kohei Yamaguchi, Japanese Clinical Medicine . 2014,第5期

机译：利拉鲁肽与西格列汀在一项为期24周，多中心，开放标签，随机，平行组的日本2型糖尿病患者对磺脲类药物和/或一种或两种其他口服抗糖尿病药物反应不佳的研究中（JDDM 33）
2. Efficacy and Safety Profile of Exenatide Once Weekly Compared With Insulin Once Daily in Japanese Patients With Type 2 Diabetes Treated With Oral Antidiabetes Drug(s): Results From a 26-Week, Randomized, Open-Label, Parallel-Group, Multicenter, Noninferiority Study [J] . InagakiN., AtsumiY., OuraT., Clinical therapeutics . 2012,第9期

机译：在口服抗糖尿病药物治疗的日本2型糖尿病患者中，艾塞那肽每周一次与胰岛素每日一次的疗效和安全性比较：一项为期26周，随机，开放标签，平行分组，多中心，非劣效性研究的结果
3. Study Protocol for a Prospective, Multicenter, Randomized, Open-Label, Parallel-Group Clinical Trial Comparing the Efficacy and Safety of a Needle-Free Insulin Injector and a Conventional Insulin Pen in Controlling Blood Glucose Concentrations in Chinese Patients with Type 2 Diabetes Mellitus (The FREE Study) [J] . Ji LiNong, Chen LiMing, Wang YanGang, Advances in therapy. . 2019,第6期

机译：研究方案的前瞻性，多中心，随机，开放标签，并联群临床试验比较无针胰岛素注射器的功效和安全性和传统的胰岛素笔控制中国2型糖尿病患者血糖浓度（免费学习）
4. A series of open-label studies comparing various formulations of orally administeredinsulin (Oralin) in patients with Type -1 Diabetes Mellitus (DM) [C] . Jaime Guevara-Aguirre, Marco Guevara, Jeannette Saavedra Annual meeting exposition of the Controlled Release Society . 2005

机译：一系列开放标签研究比较了-1型糖尿病（DM）患者口服胰岛素（Oralin）的各种配方
5. A randomized, open-label, intervention study to evaluate the effect of diet composition on weight gain in obese, type 2 diabetes patients receiving intensive insulin therapy. [D] . Villareal, Roland. 2008

机译：一项随机，开放标签，干预性研究，以评估饮食结构对接受强化胰岛素治疗的肥胖2型糖尿病患者体重增加的影响。
6. Liraglutide Versus Sitagliptin in a 24-week Multicenter Open-label Randomized Parallel-group Study in Japanese Type 2 Diabetes Mellitus Patients Responding Inadequately to a Sulfonylurea and/or One or Two Other Oral Antidiabetic Drugs (JDDM 33) [O] . Hiroki Yokoyama, Koichi Hirao, Kohei Yamaguchi, 2014

机译：利拉鲁肽与西格列汀在一项为期24周多中心开放标签随机平行组的日本2型糖尿病患者对磺脲类药物和/或一种或两种其他口服抗糖尿病药物反应不佳的研究中（JDDM 33）
7. Lifestyle modification program, LIFE is LIGHT, in patients with type 2 diabetes mellitus and obesity: Results from a 48‐week, multicenter, non‐randomized, parallel‐group, open‐label study [O] . Gagik R. Galstyan, Farida V. Valeeva, Svetlana I. Motkova, 2021

机译：生活方式修改计划，寿命是光线，患者2型糖尿病和肥胖症：48周，多中心，非随机，并行组，开放标签研究的结果

Lifestyle modification program LIFE is LIGHT in patients with type 2 diabetes mellitus and obesity: Results from a 48‐week multicenter non‐randomized parallel‐group open‐label study

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅